Back

Multisensor trends during worsening heart failure events treated with outpatient intravenous diuretics

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers and prognosis in acute heart failure Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ramesh Wariar

St Paul (United States of America)

7 More presentations in this session

Presentation thumbnail
Association between high serum uric acid and poor outcomes in patients with acute heart failure.
Doctor F. Qorina (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic performance of insulin-like growth factor-binding protein 7 in patients with acute dyspnea in the emergency department
Ms C. Popescu (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study
Ms E. Ghanbari (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
The role of exhaled breath acetone and BNP in predicting outcomes in advanced heart failure
Doctor D. Motta Da Costa Dan (Vitoria, BR)
Abstract Slides Video
Presentation thumbnail
Admission natriuresis as a predictor of outcomes in acute decompensated heart failure
Mr J. Iroulart (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers and prognosis in acute heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Remote monitoring of cardiac implantable electronic devices for predicting acute clinical decompensation events in heart failure patients: an integrated diagnostic algorithm evaluation in a real-world
thumbnail
Congress Presentation
Prognostic impact of patterns of in-hospital heart failure on clinical outcomes after myocardial infarction
thumbnail
Congress Presentation
Physiologist-led management of heart failure patients using cardiac implantable electronic device diagnostics during COVID-19: a 2-year UK perspective

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources